Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 'ALTITUDE-NASH' Liver Function Trial of Rencofilstat
Stock Information for Hepion Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.